These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 35339897)
1. Prevalence and prognostic significance of DNMT3A- and TET2- clonal haematopoiesis-driver mutations in patients presenting with ST-segment elevation myocardial infarction. Wang S; Hu S; Luo X; Bao X; Li J; Liu M; Lv Y; Zhao C; Zeng M; Chen X; Unsworth A; Jones S; Johnson TW; White SJ; Jia H; Yu B EBioMedicine; 2022 Apr; 78():103964. PubMed ID: 35339897 [TBL] [Abstract][Full Text] [Related]
3. Full spectrum of clonal haematopoiesis-driver mutations in chronic heart failure and their associations with mortality. Kiefer KC; Cremer S; Pardali E; Assmus B; Abou-El-Ardat K; Kirschbaum K; Dorsheimer L; Rasper T; Berkowitsch A; Serve H; Dimmeler S; Zeiher AM; Rieger MA ESC Heart Fail; 2021 Jun; 8(3):1873-1884. PubMed ID: 33779075 [TBL] [Abstract][Full Text] [Related]
4. Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia. Sasaki K; Kanagal-Shamanna R; Montalban-Bravo G; Assi R; Jabbour E; Ravandi F; Kadia T; Pierce S; Takahashi K; Nogueras Gonzalez G; Patel K; Soltysiak KA; Cortes J; Kantarjian HM; Garcia-Manero G Cancer; 2020 Feb; 126(4):765-774. PubMed ID: 31742675 [TBL] [Abstract][Full Text] [Related]
5. Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure. Dorsheimer L; Assmus B; Rasper T; Ortmann CA; Ecke A; Abou-El-Ardat K; Schmid T; Brüne B; Wagner S; Serve H; Hoffmann J; Seeger F; Dimmeler S; Zeiher AM; Rieger MA JAMA Cardiol; 2019 Jan; 4(1):25-33. PubMed ID: 30566180 [TBL] [Abstract][Full Text] [Related]
6. Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction. Pascual-Figal DA; Bayes-Genis A; Díez-Díez M; Hernández-Vicente Á; Vázquez-Andrés D; de la Barrera J; Vazquez E; Quintas A; Zuriaga MA; Asensio-López MC; Dopazo A; Sánchez-Cabo F; Fuster JJ J Am Coll Cardiol; 2021 Apr; 77(14):1747-1759. PubMed ID: 33832602 [TBL] [Abstract][Full Text] [Related]
7. Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation. Gibson CJ; Kim HT; Zhao L; Murdock HM; Hambley B; Ogata A; Madero-Marroquin R; Wang S; Green L; Fleharty M; Dougan T; Cheng CA; Blumenstiel B; Cibulskis C; Tsuji J; Duran M; Gocke CD; Antin JH; Nikiforow S; DeZern AE; Chen YB; Ho VT; Jones RJ; Lennon NJ; Walt DR; Ritz J; Soiffer RJ; Gondek LP; Lindsley RC J Clin Oncol; 2022 Jan; 40(2):189-201. PubMed ID: 34793200 [TBL] [Abstract][Full Text] [Related]
8. Clonal Hematopoiesis Is Associated With Long-Term Adverse Outcomes Following Cardiac Surgery. Ninni S; Vicario R; Coisne A; Woitrain E; Tazibet A; Stewart CM; Diaz LA; White JR; Koussa M; Dubrulle H; Juthier F; Jungling M; Vincentelli A; Edme JL; Nattel S; de Winther M; Geissmann F; Dombrowicz D; Staels B; Montaigne D J Am Heart Assoc; 2024 Sep; 13(17):e034255. PubMed ID: 39206728 [TBL] [Abstract][Full Text] [Related]
9. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease. Sano S; Oshima K; Wang Y; Katanasaka Y; Sano M; Walsh K Circ Res; 2018 Jul; 123(3):335-341. PubMed ID: 29728415 [TBL] [Abstract][Full Text] [Related]
10. Clonal Hematopoiesis and Bone Marrow Infiltration in Patients With Follicular Helper T-Cell Lymphoma of Angioimmunoblastic Type. Harland L; Borgmann V; Otto F; Overkamp M; Bonzheim I; Fend F; Quintanilla-Martinez L; Nann D Mod Pathol; 2024 Jul; 37(7):100519. PubMed ID: 38777036 [TBL] [Abstract][Full Text] [Related]
11. Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure. Abplanalp WT; Mas-Peiro S; Cremer S; John D; Dimmeler S; Zeiher AM JAMA Cardiol; 2020 Oct; 5(10):1170-1175. PubMed ID: 32639511 [TBL] [Abstract][Full Text] [Related]
12. TET2-Driven Clonal Hematopoiesis and Response to Canakinumab: An Exploratory Analysis of the CANTOS Randomized Clinical Trial. Svensson EC; Madar A; Campbell CD; He Y; Sultan M; Healey ML; Xu H; D'Aco K; Fernandez A; Wache-Mainier C; Libby P; Ridker PM; Beste MT; Basson CT JAMA Cardiol; 2022 May; 7(5):521-528. PubMed ID: 35385050 [TBL] [Abstract][Full Text] [Related]
13. Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1. Saadatagah S; Naderian M; Uddin M; Dikilitas O; Niroula A; Schuermans A; Selvin E; Hoogeveen RC; Matsushita K; Nambi V; Yu B; Chen LY; Bick AG; Ebert BL; Honigberg MC; Li N; Shah A; Natarajan P; Kullo IJ; Ballantyne CM JAMA Cardiol; 2024 Jun; 9(6):497-506. PubMed ID: 38598228 [TBL] [Abstract][Full Text] [Related]
14. Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis. Attygalle AD; Dobson R; Chak PK; Vroobel KM; Wren D; Mugalaasi H; Morgan Y; Kaur M; Ahmad R; Chen Z; Naresh KN; Du MQ Histopathology; 2022 Apr; 80(5):847-858. PubMed ID: 35064935 [TBL] [Abstract][Full Text] [Related]
15. Natural history of clonal haematopoiesis seen in real-world haematology settings. Patel SA; Gerber WK; Zheng R; Khanna S; Hutchinson L; Abel GA; Cerny J; DaSilva BA; Zhang TY; Ramanathan M; Khedr S; Selove W; Woda B; Miron PM; Higgins AW; Gerber JM Br J Haematol; 2024 May; 204(5):1844-1855. PubMed ID: 38522849 [TBL] [Abstract][Full Text] [Related]
16. Symptomatic Heart Failure and Clonal Hematopoiesis-Related Mutations in Patients With Acute Myeloid Leukemia. Kang Y; Lefebvre B; Pamies IM; Gill SI; Doucette AG; Denduluri S; Smith AM; McCurdy S; Luger S; Carver J; Scherrer-Crosbie M Am J Cardiol; 2024 Sep; 226():9-17. PubMed ID: 38972534 [TBL] [Abstract][Full Text] [Related]
17. DNA methyltransferase 3 alpha and TET methylcytosine dioxygenase 2 restrain mitochondrial DNA-mediated interferon signaling in macrophages. Cobo I; Tanaka TN; Chandra Mangalhara K; Lana A; Yeang C; Han C; Schlachetzki J; Challcombe J; Fixsen BR; Sakai M; Li RZ; Fields H; Mokry M; Tsai RG; Bejar R; Prange K; de Winther M; Shadel GS; Glass CK Immunity; 2022 Aug; 55(8):1386-1401.e10. PubMed ID: 35931086 [TBL] [Abstract][Full Text] [Related]
18. Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging. Jakobsen NA; Turkalj S; Zeng AGX; Stoilova B; Metzner M; Rahmig S; Nagree MS; Shah S; Moore R; Usukhbayar B; Angulo Salazar M; Gafencu GA; Kennedy A; Newman S; Kendrick BJL; Taylor AH; Afinowi-Luitz R; Gundle R; Watkins B; Wheway K; Beazley D; Murison A; Aguilar-Navarro AG; Flores-Figueroa E; Dakin SG; Carr AJ; Nerlov C; Dick JE; Xie SZ; Vyas P Cell Stem Cell; 2024 Aug; 31(8):1127-1144.e17. PubMed ID: 38917807 [TBL] [Abstract][Full Text] [Related]
19. Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome. Sano S; Oshima K; Wang Y; MacLauchlan S; Katanasaka Y; Sano M; Zuriaga MA; Yoshiyama M; Goukassian D; Cooper MA; Fuster JJ; Walsh K J Am Coll Cardiol; 2018 Feb; 71(8):875-886. PubMed ID: 29471939 [TBL] [Abstract][Full Text] [Related]
20. Combined Effects of Clonal Hematopoiesis and Carotid Stenosis on Cardiovascular Mortality. Jäger R; Hoke M; Mayer FJ; Boden S; Englisch C; Ay C; Kralovics R; Binder CJ J Am Coll Cardiol; 2024 May; 83(18):1717-1727. PubMed ID: 38692825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]